Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus

Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease. Although previous studies have demonstrated that SLE is related to the imbalance of cells in the immune system, including B cells, T cells, and dendritic cells, etc., the mechanisms underlying SLE pathogenesis remain unclear. Theref...

Full description

Bibliographic Details
Main Authors: Aifen Li, Fengbiao Guo, Quanren Pan, Shuxian Chen, Jiaxuan Chen, Hua-feng Liu, Qingjun Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
systemic lupus erythematosus
mesenchymal stem cells
immunomodulation
transplantation
inefficacy
modification
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.728190/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.728190/full

Similar Items